AI pathology aid developer Medmain, a Kyushu Universty-aligned startup, will use the capital to support international expansion.
Medmain, a Japan-based pathology assistant software developer aligned to Kyushu University, has secured ¥1.1bn ($10.3m) from investors including IHW Group, operator of medical university International University of Health and Welfare, The Bridge reported on Wednesday.
Tokyo Institute of Technology’s Innovations and Future Creation also took part, as did health system Fukuoka Wajiro Hospital Group, telecoms group SoftBank’s Deepcore fund, consultancy Dogan’s investment arm Dogan Beta, QTnet, Hike Ventures and unnamed angel investors.
Hike Ventures leveraged a special purpose…
